Involvement of aspirin-sensitive oxylipins in vulvovaginal candidiasis

FEMS Microbiology Letters

Volumn 198, Issue 1, 2001, Pages 37-43

  Deva, Rupal ^a   Ciccoli, Roberto ^a   Kock, Lodewyk ^b   Nigam, Santosh ^a  

^a Inst Pflanzenvirologie M   (Germany)

^b UNIVERSITY OF THE FREE STATE   (South Africa)

Author keywords

3(R) Hydroxyoxylipin; Acetylsalicylic acid; Candida albicans; Clotrimazole; Immunofluorescence microscopy; Vulvovaginal candidiasis

Indexed keywords

3 HYDROXYOXYLIPIN DERIVATIVE; ACETYLSALICYLIC ACID; CLOTRIMAZOLE; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ARTICLE; CANDIDA ALBICANS; FEMALE; FUNGUS GROWTH; GROWTH INHIBITION; HELA CELL; HUMAN; LIPOGENESIS; PRIORITY JOURNAL; VAGINA CANDIDIASIS;

ANTIFUNGAL AGENTS; ARACHIDONIC ACIDS; ASPIRIN; CANDIDA ALBICANS; CANDIDIASIS, VULVOVAGINAL; CLOTRIMAZOLE; DINOPROSTONE; FEMALE; HELA CELLS; HUMANS; MICROSCOPY, FLUORESCENCE; RECURRENCE;

EID: 0035917482     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(01)00114-8     Document Type: Article

References (21)

1. Odds, F.C. (1998) Genital candidosis. In: Candida and Candidosis; a Review and Bibliography (Odds, F.C., Ed.), pp. 124-35. Baillière Tindall, London.
2. Eckert L.O., Hawes S.E., Stevens C.E., Koutsky L.A., Eschenbach D.A., Holmes K.K. Vulvovaginal candidiasis: Clinical manifestations, risk factors, management algorithm. Obstet. Gynecol. 92:1998;757-765.
3. Van den Bossche, H. (1995) Chemotherapy of human fungal infections. In: Modern Selective Fungicides, 2nd edn. (Lyr, H., Ed.), pp. 431-484. Gustav Fischer Verlag, Jena.
4. Milsom I., Forssman L. Repeated candidiasis: Reinfection or recrudescence? A review. Am. J. Gynecol. Obstet. 152:1985;956-959.
5. Odds F.C. Morphogenesis in Candida albicans. Crit. Rev. Microbiol. 12:1985;45-93.
6. Datta A., Ganesan K., Natarajan K. Current trends in Candida albicans research. Adv. Microbial. Physiol. 30:1989;53-88.
7. Lindler G.E.M., Plantema F.H.F., Hoogkamp-Korstanje J.R.A. Quantitative studies of the vaginal flora of healthy women and of obstetric and gynecologic patients. J. Med. Microbiol. 11:1978;233-241.
8. Deva R., Ciccoli R., Schewe T., Kock J.L.F., Nigam S. Arachidonic acid stimulates cell growth and forms a novel oxygenated metabolite in Candida albicans. Biochim. Biophys. Acta. 1486:2000;299-311.
9. van Dyk M.S., Kock J.L.F., Coetzee D.J., Augustyn O.P.H., Nigam S. Isolation of a novel arachidonic acid metabolite 3-hydroxy-5,8,11,14-eicosatetraenoic acid (3-HETE) from the yeast Dipodascopsis uninucleata. FEBS Lett. 283:1991;195-198.
10. Venter P., Kock J.L.F., Jansen van Vuuren D., Botha A., Coetzee D.J., Botes P.J., Bhatt R.K., Falck J.R., Schewe T., Nigam S. Production of 3R-hydroxy-polyenoic fatty acids by the yeast Dipodascopsis uninucleata. Lipids. 32:1997;1277-1283.
11. Pohl, C.H., Botha, A., Kock, J.L.F., Coetzee, D.J., Botes, P.J., Schewe, T. and Nigam, S., Oxylipin formation in fungi: biotransformation of arachidonic acid to 3-hydroxy-5,8-tetradecadienoic acid by Mucor genevensis. Biochem. Biophys. Res. Commun. 253, 703-706.
12. Kock J.L.F., Venter P., Linke D., Schewe T., Nigam S. Biological dynamics and distribution of 3-hydroxy fatty acids in the yeast Dipodascopsis uninucleata as investigated by immunofluorescence microscopy. Evidence for a putative regulatory role in the sexual reproductive cycle. FEBS Lett. 427:1998;345-348.
13. Herman, R.P. (1998) Oxylipin production and action in fungi and related organisms. In: Eicosanoids and Related Compounds in Plants and Animals (Rowley, A.F., Kühn, H. and Schewe, T., Eds.), pp. 115-30. Portland Press, London.
14. Hull C.M., Johnson A.D. Identification of a mating type-like locus in the asexual pathogenic yeast Candida albicans. Science. 285:1999;1271-1275.
15. Ha K.C., White T.C. Effect of azole antifungal drugs on the transition from yeast cells to hyphae in susceptible and resistant isolates of the pathogenic yeast Candida albicans. Antimicrob. Agents Chemother. 43:1999;763-768.
16. Lo H.-J., Köhler J.R., diDomenico B., Loebenberg D., Cacciapuoti A., Fink G.R. Nonfilamentous C. albicans mutants are avirulent. Cell. 90:1997;939-949.
17. Goyal S., Khuller G.K. Structural and functional role of lipids in yeast and mycelial forms of Candida albicans. Lipids. 29:1994;793-797.
18. Castro M., Ralston N.V.C., Morgenthaler T.I., Rohrbach M.S., Limper A.H. Candida albicans stimulates arachidonic acid liberation from alveolar macrophages through α-mannan and β-glycan cell wall components. Infect. Immun. 62:1994;3138-3145.
19. Filler S.G., Ibe B.O., Luckett P.M., Raj J.U., Edwards J.E. Jr. Candida albicans stimulates endothelial cell eicosanoid production. J. Infect. Dis. 164:1991;928-935.
20. 2 enhances and gamma interferon inhibits germ tube formation in Candida albicans. Infect. Immun. 58:1990;260-262.
21. Glasgow J.F.T., Middleton B., Moore R., Gray A., Hill J. The mechanism of inhibition of β-oxidation by aspirin metabolites in skin fibroblasts from Reye syndrome patients and controls. Biochim. Biophys. Acta. 1454:1999;115-125.